Is HHC legal in United Arab Emirates?

Legal status

Hexahydrocannabinol is in Schedule 1 of Decision No. 158 of 2025 as a current national addition made in the 2025 republication of the schedules, at the printed entry «هكساهيدروكانابينول؛ HHC». The dossier treats the 2025 republication as the fact that closes this row: the compound is named expressly in both the Arabic and the abbreviated form, so it does not depend on being read into a tetrahydrocannabinol entry. Its placement in Schedule 1 rather than in the psychotropic schedules is notable, because the same instrument carries the specified tetrahydrocannabinol variants in Schedule 5, and the dossier's cannabinoid searches on other rows record hexahydrocannabinol as present while cannabidiol and cannabinol are not. The row runs through Articles 10, 41 and 57, with Schedule 10 carrying the quantity bands. The placement was read on 20 September 2026.

Consequences if caught

Schedule 1 is one of the four schedule groups Article 57 names, and the hexahydrocannabinol entry is a Schedule 1 entry, so a cannabinoid marketed in several countries as a lawful alternative to tetrahydrocannabinol sits in the narcotics schedule here. The dossier records Article 57 as stating mandatory death for its trafficking or promotion trigger and as stating no quantity, and records that the Schedule 10 bands do not gate that route. The distance between how this compound is sold and where it is scheduled is the whole of the risk, and the recency of the addition makes it worse rather than better, because a traveller's information about it is likely to predate the 2025 republication. Article 41 carries the personal use route for this branch, with its tariff unstated.

If prescribed or medical

The dossier records at the modafinil row that a 268 entry ministry travellers list was checked and expressly not used as a schedule. Attached to this substance: hexahydrocannabinol is in Schedule 1 as a 2025 national addition, and the dossier records no medicinal product, prescribing route or permit against that entry. Dronabinol and nabilone appear in the dossier's cannabinoid searches as separately named substances, which is not a route for this compound, so the medical question here is deferred rather than borrowed.

Documentation

No documentation route is recorded for hexahydrocannabinol, and a vendor's compliance statement from a jurisdiction where it is sold is not an Emirati authorisation. Provenance: the entry «هكساهيدروكانابينول؛ HHC» and its Schedule 1 placement as a current 2025 national addition were read on 20 September 2026, with the capital analysis resting on Article 57 and not on the Schedule 10 bands. The practical point is that the addition is recent, so any guidance about this compound that predates the 2025 republication should be treated as out of date rather than as a second opinion.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with United Arab Emirates’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.